Navigation Links
Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
Date:12/9/2008

TORONTO, Dec. 9 /PRNewswire/ - Interface Biologics Inc. - a privately held developer of novel biomedical-polymers for use in implantable medical devices - is announcing that it has secured a $5mm financing round. Participating in the round were existing investors Covington Capital, VG Partners and BDC Capital. In connection with the financing, Lily Lam from Covington Capital is joining the Board of Directors and Thomas P. Reeves has been appointed the new President and CEO and is also joining the Board of Directors.

"We are fully committed to Interface Biologics and are excited about the continued commercialization opportunities for the Company in the near future. We're pleased to have Tom Reeves joining the Interface team and believe his broad leadership experience - most recently as President and COO of OccuLogix, a medical device company focused on treating age related diseases from the eye (NASDAQ) - will complement our existing scientific and technical expertise as we move into the clinical application and commercialization phase with many of the Company's novel polymer products," said Jeff Courtney, General Partner of VG Partners. "We are also excited to welcome Lily Lam, Vice President Investments, from Covington Capital to the Board of Directors."

"The fact that Interface has been able to raise a significant new round of financing in these difficult economic times is testament to the strength of the organization and its unique products in key applications and rich IP that crosses the spectrum of medical devices," said Tom Reeves, President and CEO of Interface Biologics, Inc. "I am pleased to be joining the Interface team and look forward to leading the team as we capitalize on the research and development work that is solidly established and execute on the commercialization of a number of the products in our portfolio."

About Interface Biologics: Interface Biologics is a biomaterials company based in Toronto, Cana
'/>"/>

SOURCE Interface Biologics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter
2. Savient Submits Biologics License Application (BLA) for pegloticase
3. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
4. Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
5. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
6. NuVasive Completes Acquisition of Osteocel Biologics Business
7. Pinnacle Biologics Announces Agreement With pharmexx to Expand Sales Support Activities in Key European Markets
8. Pinnacle Biologics Announces Opening of Executive Offices in Bannockburn, Illinois and the Addition of Sandra Miller to the Board of Directors
9. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
10. Pinnacle Biologics Announces Contract With Chiltern
11. Pinnacle Biologics Announces Logistics Services Agreement With the Movianto Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... AMHERST, Mass. Using a bio-mimicking analog of ... of grass, an international research team led by ... has taken a major step in developing long-sought ... to electricity for use in electronic devices. ... UMass Amherst and others at Stanford University and ...
(Date:9/30/2014)... Sept. 30, 2014 Nematicide is a ... Nematodes are microscopic parasitic roundworms, found in massive ... other plants and animals. Nematicides have tended to ... properties promoting migration through the soil. A single ... plant-parasitic nematodes. With more than 10,000 species classified, ...
(Date:9/30/2014)... , Sept. 30, 2014  RegeneRx Biopharmaceuticals, Inc. ... that it has received a Canadian Patent for ... Peptides.  This patent includes claims using thymosin beta ... actin-sequestering peptides for these purposes.  The patent will ... Biopharmaceuticals, Inc. ( www.regenerx.com ) ...
(Date:9/30/2014)... CA (PRWEB) September 30, 2014 OriginOil ... the high-speed, chemical-free process to clean up large quantities ... shareholders, CEO Riggs Eckelberry reported on the launch of ... at a site provided by partner STW Resources ... to 1000 barrels per day (bpd) and achieved a ...
Breaking Biology Technology:Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3Nematicides Market by Types (Fumigants, Organophosphates, Carbamate and Bio-Nematicides), Applications (Agrochemicals, Industrial, and Others), and Geography (North America, Europe, Asia-Pacific & ROW) - Global Trends & Forecasts to 2019 2RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2
... , DeKalb, Ill. Scientists at Northern Illinois University ... high yields of graphene, a highly touted carbon nanostructure ... fabric of the future. The focus of intense ... material, comprised of a single layer of carbon atoms ...
... Netsmart Technologies, Inc. ( www.ntst.com ... for health and human services organizations, today announced ... software for behavioral health provider organizations has achieved ... (Logo: http://photos.prnewswire.com/prnh/20110620/NY22778LOGO) "We are fully committed ...
... Neogen Corporation (NASDAQ: NEOG ) announced today ... seafood testing laboratory from its parent company, GlycoMar Ltd. ... services to the shellfish and salmon aquaculture industries. VeroMara,s ... including E. coli , noroviruses, and salmon husbandry. ...
Cached Biology Technology:Northern Illinois University scientists find simple way to produce graphene 2CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification 2CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification 3CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification 4Neogen Acquires VeroMara from GlycoMar Ltd. 2
(Date:9/30/2014)... to tetrachloroethylene (PCE) in drinking water may increase ... to a new study led by a Boston ... study, published in the journal Environmental Health ... pregnancies among 1,766 women in Cape Cod, Ma., ... to the early 1980s by the installation of ...
(Date:9/30/2014)... live in almost any aquatic environment on Earth, but ... species are pushed to the limit. The amount of ... critical for how different species cope in the future, ... of Gothenburg, published in the scientific journal Proceedings ... continues apace thanks to increasing levels of greenhouse gases ...
(Date:9/30/2014)... and farm runoff in Hawaii is causing tumors in ... The study, published Tuesday in the peer-reviewed open-access journal ... ends up in algae that the turtles eat, promoting ... and internal organs. , Scientists at Duke University, the ... Administration (NOAA) conducted the study to better understand the ...
Breaking Biology News(10 mins):Contaminated water linked to pregnancy complications, BU study finds 2Shape up quickly -- applies to fish, too! 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3
... is available in German . , What is ... what do they mean for the nutrition and balance of a ... growing data streams even in mobile internet access? How do the ... this view imply for the interpretation of artistic creations in general? ...
... Singapore, May 9, 2012 Researchers at the ... bioengineering and nanotechnology research institute, have developed a miniaturized ... stem cells (CSCs). Published recently in Nano Today ... more effective cancer drugs. In a tumor, CSCs ...
... on behalf of the European Pet Food Industry Federation ... A consumption for puppies. The research marks a significant ... vitamin A levels for puppies and sheds new light ... was conducted by scientists from the Free University of ...
Cached Biology News:DFG establishes 10 new priority programs 2DFG establishes 10 new priority programs 3IBN's Droplet Array sheds light on drug-resistant cancer stem cells 2IBN's Droplet Array sheds light on drug-resistant cancer stem cells 3Collaborative research team identifies safe upper level for vitamin A consumption for puppies 2
... BD Pathway Bioimager is an automated, confocal, ... system that has been integrated into a ... was designed to provide high-resolution, automated confocal ... in developing better cell-based assays. The system ...
... The BD CARV II Confocal Imager delivers ... easy to use and cost effective optical ... High speed multi-point confocal scanning, combined with ... and allows real-time imaging and recording at ...
... Kit uses a simplified procedure and streamlines ... The kit is based on the three ... and sodium bisulfite where cytosine is converted ... innovative in-column desulphonation reaction eliminates several precipitation ...
... MG Phosphate Assay Kit is based on ... Malachite Green, molybdate and free orthophosphate. The ... be conveniently measured on a spectrophotometer (600-660 ... non-radioactive colorimetric assay kits have been optimized ...
Biology Products: